doi: 10.1080/14740338.2016.1186642.
Epub 2016 May 23.
Manufacturers' promotion of off-label drug use: implications for drug safety
Affiliations
- PMID: 27145440
- DOI: 10.1080/14740338.2016.1186642
Item in Clipboard
Manufacturers' promotion of off-label drug use: implications for drug safety
Expert Opin Drug Saf.
2016 Sep.
No abstract available
Keywords: Drug safety; First Amendment; Food and Drug Administration; off-label promotion.
Similar articles
-
Off-label prescription advertising, the FDA and the First Amendment: a study in the values of commercial speech protection.Am J Law Med. 2011;37(2-3):315-57. doi: 10.1177/009885881103700206. Am J Law Med. 2011. PMID: 21847884 No abstract available.
-
Off-label promotion: government theories of prosecution and facts that drive them.Food Drug Law J. 2010;65(3):555-88. Food Drug Law J. 2010. PMID: 24479242 No abstract available.
-
Hidden truth: The perils and protection of off-label drug and medical device promotion.Health Matrix Clevel. 2011;21(1):149-87. Health Matrix Clevel. 2011. PMID: 21847900 No abstract available.
-
Direct-to-consumer prescription drug advertising.Am J Law Med. 1999;25(1):149-67. Am J Law Med. 1999. PMID: 10207573 Review. No abstract available.
-
A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation.Int J Risk Saf Med. 2014;26(4):213-25. doi: 10.3233/JRS-140635. Int J Risk Saf Med. 2014. PMID: 25420763 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
